Stocks and Investing Stocks and Investing
Wed, January 6, 2021
Tue, January 5, 2021

Do Kim Initiated (ABCL) at Buy and Held Target at $48 on, Jan 5th, 2021


Published on 2024-10-27 15:06:25 - WOPRAI, Do Kim
  Print publication without navigation


Do Kim of BMO Capital, Initiated "AbCellera Biologics Inc." (ABCL) at Buy and Held Target at $48 on, Jan 5th, 2021.

Do, nor any peers, have made any analyst calls on ABCL in the last 4 months.

Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30

Contributing Sources